A detailed history of Jpmorgan Chase & CO transactions in Liva Nova PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 205,452 shares of LIVN stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205,452
Previous 474,561 56.71%
Holding current value
$10.1 Million
Previous $26.5 Million 57.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$51.76 - $64.15 $13.9 Million - $17.3 Million
-269,109 Reduced 56.71%
205,452 $11.3 Million
Q1 2024

May 10, 2024

BUY
$48.6 - $57.12 $15.1 Million - $17.7 Million
310,574 Added 189.39%
474,561 $26.5 Million
Q4 2023

Feb 12, 2024

SELL
$43.45 - $53.66 $655,486 - $809,514
-15,086 Reduced 8.42%
163,987 $8.48 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $1.46 Million - $1.72 Million
-29,217 Reduced 14.03%
179,073 $9.47 Million
Q2 2023

Aug 11, 2023

SELL
$42.28 - $51.43 $2.46 Million - $2.99 Million
-58,186 Reduced 21.84%
208,290 $10.7 Million
Q1 2023

May 18, 2023

BUY
$40.84 - $58.14 $5.44 Million - $7.74 Million
133,128 Added 99.84%
266,476 $11.6 Million
Q1 2023

May 11, 2023

SELL
$40.84 - $58.14 $5.26 Million - $7.48 Million
-128,693 Reduced 49.11%
133,348 $5.81 Million
Q4 2022

Feb 13, 2023

BUY
$43.88 - $56.16 $179,556 - $229,806
4,092 Added 1.59%
262,041 $14.6 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $198,945 - $273,514
-4,113 Reduced 1.57%
257,949 $13.1 Million
Q2 2022

Aug 11, 2022

SELL
$57.25 - $86.63 $709,671 - $1.07 Million
-12,396 Reduced 4.52%
262,062 $16.4 Million
Q1 2022

May 11, 2022

BUY
$71.02 - $86.99 $3.53 Million - $4.33 Million
49,746 Added 22.14%
274,458 $22.5 Million
Q4 2021

Feb 10, 2022

BUY
$76.72 - $92.68 $306 - $370
4 Added 0.0%
224,712 $19.6 Million
Q3 2021

Nov 12, 2021

BUY
$76.02 - $88.62 $17.1 Million - $19.9 Million
224,708 New
224,708 $17.8 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.62B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.